Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations
    Meeting Abstract

    Xing, F.; Persaud, Y.; Pratilas, C.; Janakiraman, M.; She, Q. B.; Liu, C.; Dolgalev, I.; Heguy, A.; Wolchok, J.; Cobrinik, D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Expression of Id4, a BRCA1 downregulator, in triple negative breast cancer
    Meeting Abstract

    Wen, Y. H.; Akram, M.; Nehhozina, T.; Bowser, Z.; Norton, L.; Brogi, E.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Morphology and immunophenotype of ductal carcinoma in situ in triple negative breast cancer
    Meeting Abstract

    Wen, Y. H.; Akram, M.; Nehhozina, T.; Mohammed, H.; Norton, L.; Brogi, E.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Genetic variation of human MDM4 confers increased risk to breast cancer in Ashkenazi Jewish (AJ) population
    Meeting Abstract

    Vijai, J.; Gaudet, M. M.; Dutra Clarke, A.; Hansen, N.; Devlin, V.; Kauff, N.; Hudis, C. A.; Bond, G. L.; Offit, K.; Kirchhoff, T.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Stat3 signaling in thyroid cancer
    Meeting Abstract

    Silva, J.; Soares, P.; Trovisco, V.; Knauf, J.; Fagin, J.; Bromberg, J.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Alternate mechanisms of PI3K pathway activation among subtypes of ductal carcinoma in situ suggest distinct pathways for progression to invasive disease
    Meeting Abstract

    Sakr, R.; Chandarlapaty, S.; Barbashina, V.; Andrade, V.; Heguy, A.; Morrogh, M.; Olvera, N.; Paik, W.; Arroyo, C.; Morrow, M.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • AZD8055 is an effective inhibitor of mTOR kinase signaling and breast cancer growth while relieving feedback inhibition of HER-kinase signaling
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Cao, N.; Chandarlapaty, S.; She, Q. B.; Ye, Q.; Smith, P.; Guichard, S.; Rosen, N.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Fine mapping of 5p12 locus in Ashkenazi Jewish breast cancer cases and controls
    Meeting Abstract

    Kirchhoff, T.; Vijai, J.; Pal, P.; Gaudet, M. M.; Devlin, V.; Dutra Clarke, A.; Waisfiz, Q.; Hudis, C. A.; Offit, K.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Adjuvant trastuzumab reduces locoregional recurrence in women who undergo breast conservation therapy for node-negative HER2-positive breast cancer
    Journal Article

    Kiess, A. P.; Mcarthur, H. L.; Mahoney, K.; Patil, S.; Morris, P. G.; Ho, A.; Hudis, C. A.; McCormick, B.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner
    Meeting Abstract

    Joseph, E. W.; Pratilas, C. A.; Poulikakos, P. I.; Tadi, M.; Wang, W.; Taylor, B. S.; Persaud, Y.; Xing, F.; Halilovic, E.; Viale, A.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save